Magnetic resonance angiography (MRA) is a non-invasive technology that can be used for diagnosis and monitoring of cardiovascular disease; the number one cause of mortality worldwide.
Introduction
Angiographic techniques are important in the diagnosis and treatment of medical conditions such as emboli, stenosis and intracranial aneurysms. The most frequently applied angiographic techniques are ultrasound imaging (US), computed tomography (CT), and nuclear medicine imaging such as PET [1] . US is non-invasive, but has its limitations in imaging of the cerebrovascular system, where cranium and tissue-bone interfaces cause attenuation and disturbance of the signal. CT provides high resolution images within short acquisition time, but the radiation exposure is a major limitation of repeated use. PET angiography can provide information about the functional metrics in the vascular system, however the low spatial resolution and the administration of radioactive contrast agent makes PET less preferable [2, 3] . Magnetic resonance angiography (MRA) is generally used with a contrast agent based on e.g. gadolinium [4] that reduces the T 1 of the blood, but flow-dependent techniques such as time-offlight (TOF) or phase contrast can also be employed without injections [5, 6] . One class of MRA contrast agents includes blood pool agents such as Clariscan™; ultra-small super paramagnetic iron oxide particles that stay in circulation for hours [7] . Thus, the arterial vascular system alone can be imaged during the first pass of the contrast agent, whereas the entire vascular system can be acquired in a large time window allowing signal averaging for high resolution. Time-resolved fast imaging can be applied to capture the dynamics [8] .
Hyperpolarized 13 C MRA
Conventional coronary proton MRA acquisition time depends on parameters such as matrix size and repetition time, and is typically acquired over several minutes [9] . Thus, respiratory and cardiac motion, as well as movements of the patient will affect the image quality. The need for faster image acquisition has catalyzed research in hyperpolarized (HP) MRI, where the signal can be enhanced by orders of magnitude compared to the thermal signal [10] . The polarization is obtained via dissolution Dynamic Nuclear Polarization (DNP): The sample is mixed with an Electron Paramagnetic Agent (EPA) and cooled to low temperature in a magnetic field, by which the unpaired electrons of the EPA reach a polarization of unity. The polarization of the electrons is transferred to the nuclear spins by irradiating with microwaves at the resonance frequency of the electrons. The high polarization of the nuclear spins are preserved to the liquid phase by rapidly dissolving in a dissolution medium, before the agent is injected. The polarization of the injected volume is more than 4 orders of magnitude larger than the thermal signal of 13 C. Therefore, the signal in a 13 C image obtained after injection of a hyperpolarized substance is proportional to the concentration of the agent in question, and the image acts as a qualitative map of perfusion [11] [12] [13] [14] . Likewise, the conversion of hyperpolarized 13 C-labelled compounds such as pyruvate can be followed with Magnetic Resonance Spectroscopic Imaging (MRSI) [15] [16] [17] , and the metabolic activity monitored [18] .
Hyperpolarized MRA provides imaging of the injected substance in the vascular system, and thus provides a direct signal from the hyperpolarized spins in the blood. In addition, hyperpolarized MRA is not dependent on flow velocity as e.g. TOF-imaging, where flow close to the vessel walls appears with a low signal due to low flow velocity. In 2002 Golman et al. demonstrated that angiography in rats using hyperpolarized 13 C is possible with bis-1,1-(hydroxymethyl)-[1-13 C]cyclopropane-D8 (HP001) as imaging agent and demonstrated that both ParaHydrogen-Induced Polarization (PHIP) [19] and dissolution DNP [20] can be used for hyperpolarized 13 C angiography with i.v. agent administration ( Figure 1 ). Svensson et al. [21] studied 13 C cerebral MRA in the rat and found that high SNR can be obtained in both the head and neck area ( Figure 2 ) and in the thoracic/abdominal region using the balanced steady state free precision pulse sequence (bSSFP). Later, Olsson et al. [22] presented a study on hyperpolarized 13 C coronary MRA in a pig model with i.a. injection. Recently, hyperpolarized H 2 O has been applied in angiography with the advantage of applicability on clinical scanners with 1 H channels only, as well as higher achievable magnetization due to a larger magnetic moment [23] .
For cerebral angiography in the rat, the hyperpolarized substance is typically injected using either intravenous (i.v.) injection through one of the tail veins, or intra-arterial (i.a.) injection where a catheter is operated into one of the carotid arteries. The injection method affect the system in various ways and e.g. movement of the catheter and the reaction of the vessels to increased pressure will result in difference in signal-to-noise ratio (SNR) and artefacts in the images. Thus, the MR sequence must be chosen and optimized in accordance with the injection method. Furthermore, the injection type will enhance specific characteristics of the arterial and venous network. An even distribution in the vasculature should be observed with an intravenous injection when the hyperpolarized substance is distributed through the heart of the animal. When the substance is injected in a carotid artery, only arteries branching from that specific carotid artery as well as the corresponding veins are highlighted.
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The 13 C-labelled agent HP001 is chosen for its long T 1 (in vitro, 2.35 T: T 1 ≈ 82 s, T 2 ≈ 18 s; in vivo, 2.35 T: T 1 ≈ 38 s, T 2 ≈ 1.3 s) [21] . This means that the signal decay should be caused mainly by dilution in the vasculature and extravasation of the agent to the surrounding tissue, and to a smaller extent by relaxation processes.
The bSSFP imaging technique has been demonstrated to be a rapid, high-SNR technique for angiography and spectroscopic applications using hyperpolarized substances ( Figure 2 ) [21, 22, 24, 25] . The gradient echo (GRE) technique has been used extensively for single resonance HP lung imaging [26] [27] [28] , but less for HP-angiography using 13 C-labeled substances. A theoretical basis and in vitro measurement comparison between bSSFP and GRE for the HP angiography application was performed by Svensson et al. [21] , but in vivo comparisons between the combinations of the two imaging techniques (bSSFP and GRE) and the two injection techniques (i.v. and i.a.) is to our knowledge not performed.
In this review we demonstrate the current possibilities of a hyperpolarized 13 C-labelled agent for MRA and investigate the difference between intravenous and intra-arterial injection with the GRE and bSSFP imaging sequences.
Methods

Polarization
Bis-1,1-(hydroxymethyl)-[1-13 C]cyclopropane-D8 (HP001) was used as the imaging agent to obtain long relaxation times of the 13 All animal experiments were carried out in compliance with the guidelines for use and care of laboratory animals and were approved by the Danish Inspectorate of Animal Experiments, approval 2012-15-2934-00244.
Male Sprague Dawley rats weighing 240-320 g were anaesthetized with 1.8% isoflurane in air mixed with 5 % oxygen adjusted to a respiration rate of 75±10 min -1 and mounted in an animal holder. The body temperature was kept at 38±1 °C with hot air flow.
Tail vein catherization:
A catheter was inserted in a tail vein for i.v. contrast agent administration. A volume of 1.5 mL was injected over 6-9 s.
Carotid artery catherization: Carotid artery injections were prepared by incision in the ventral neck of the rat and isolation of the right carotid artery, before inserting and securing the catheter in the artery. The catheter was fixed to the skin with tape. A volume of 1.0 mL was injected over 6-9 s.
MR scanner system and pulse sequences:
Data was acquired on a 4.7 T imaging system (Agilent, Direct Drive, VnmrJ 4.0) using a 13 C/ 1 H RF volume coil combined with a 13 C 4-channel surface array coil (receive-only, 50 mm inner diameter, RAPID Biomedical GmbH, Germany). The receive coil was placed dorsal with the animal supine. Figure 3 shows the profile of the coil sensitivity measured as the sum-of-squares image of a CSI acquisition of a spherical bicarbonate phantom. The position of the GRE slab is indicated as the shaded area. The bSSFP slab is overlapping, but extends 10 mm in the anterior direction. The sensitivity is highest in the region closest to the coil elements, thus the sensitivity of the vessels in this region is more than twice the sensitivity in the outer region of the slab. The system was shimmed to a proton line width of less than 110 Hz over the field-of-view (FOV). The image reconstruction applied the sum-ofsquares algorithm where the signal in each pixel is the square root of the sum of the squares of the signal from each individual array coil element. The background noise is measured in a ROI of 20x20 pixels in an area away from the hyperpolarized signal. Acquisition was started when injection was initiated to capture the maximum signal strength. HP-13 C-MRA, GRE: An excitation pulse flip angle of 5° was found the optimal compromise between signal strength and conversion of magnetization during the time series in a separate study (data not shown). A time series of 8 frames during intra-arterial injection is shown in Figure 5 . The best image is the 4 th time frame. The rat brain was centered in the FOV, and arteries and veins of the right side of the head appear with the largest denseness around the brain and towards the nose region. Only a few veins appear in the left half of the image, and only minor signal contribution is visible in the eye region of the right side. Figure 6 shows the 4 th frame as overlay on the proton The corresponding GRE acquisition after an intravenous injection yielded signal from the larger veins but with SNR lower than 10 (acquired in 3 animals, image not shown).
HP-13 C-MRA, bSSFP:
The signal acquisition bandwidth was studied in the range of 20-100 kHz, and we found 50 kHz to be the optimal balance between high signal and minimal flow artefacts. The sequence was started when the solution had been fully injected to capture the maximum possible signal. In separate experiments (data not shown), the flip angle for the bSSFP-sequence was optimized on thermal phantom experiments where a flip angle of 110° yielded a 22% higher SNR than the corresponding experiment with 60° flip angle and where flip angles higher than 110° did experiments on HP in vivo experiments with the bSSFP (data not shown). A time series of bSSFP acquired images with one second intervals is shown in Figure 7 . SNR of 36 is observed in the first frame and the signal decays rapidly in the following frames. The larger veins (SSS, TRS, STEMV) identified from the overlay appear distinctly in a symmetrical shape, and smaller venal structure appears towards the nose region. 5 injections in 4 different animals yielded SNR of 31.3±20.0 (Mean±SD).
Discussion
In this study we injected a dose close to the anticipated clinical dose of ca. 0.4 mmol/kg, which is only 25-50% of the dose used in previous studies with a similar polarization. We obtained results similar to Golman et al., where an SNR of 34 was demonstrated in a 128x128 matrix (70x70 mm 2 ) in the rat heart with an injection of 2-3 mL of 200 mM (ca. 1.5 mmol/kg) solution with polarization of ca. 15% [19] . Svensson et al. obtained SNR of 74-76 in a lower resolution of a 64x64 matrix (70x70 mm 2 ) placed in the rat head and neck region with injection of 3-3.5 mL of 200 mM solution with a polarization of ca. 15% [21] .
The bSSFP sequence proved best for injections through the tail vein where the physiological and physical reactions of the animal are negligible, in contrary to injections through a carotid artery, which caused minor mechanical movements of the neck and head region where the catheter is inserted, as well as possible physiological reactions in the imaged region due to the injected bolus' impact on the vessels due to pressure, pH, temperature and tonicity.
These movements caused motion artefacts in the bSSFP acquisition, whereas a GRE sequence was more robust to displacements and hence better suitable. Images of carotid artery injection acquired with bSSFP ( Figure 8 ) showed a very high SNR of 137. Even though this large signal from the high agent concentration in the arteries was observed, the details of the vascular system were indistinguishable. The sequence was applied with TR/TE = 6.95/3.48 ms, α = 60° in a 128x128 matrix with FOV 60x60 mm 2 in a 30 mm slab. The strong artefacts may be caused by motion due to the injection as well as B 0 -field disturbances caused by the large difference in oxygenated blood and the water introduced with the injection [29] .
The contrast agent is further diluted for tail vein injections. The combination of small flip angle GRE acquisition and large dilution in the vascular system resulted in SNR below 10. Therefore, a bSSFP sequence with high flip angle is preferred.
The bSSFP-sequence had a slab thickness of 30 mm. In some experiments, the transverse sinuses align orthogonally to the slice and thus contribute with a large signal in the projection (arrow in Figure 7 ). These outliers cause the large variance where single pixels have yielded signal strength much larger than the rest of the vasculature.
Large parts of the image characteristics in Figure 5 are observed throughout the series, while some features are vanishing in the later time steps. The fact that the operated carotid has been sealed off beneath the catheter explains that some of the branches have closed off during several hours of occlusion in the scanner. The image series and the consistency in the SNR indicate that polarization, injection and data acquisition is reproducible.
When the bSSFP sequence was applied following an intra-arterial injection we observe motion artefacts in the phase encoding direction as shown in Figure 8 .
Polarizers for DNP have now been installed in several clinics around the world, and studies of HP 13 C in humans initiated [30] . As this equipment is being implemented, the application of hyperpolarized agents for angiography in will be further studied, and a potential translation towards application in clinical practice explored.
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In conclusion, intravenous and intra-arterial injection techniques were used in combinations with optimized GREand bSSFP-imaging, respectively, for rat cerebral MRA with a hyperpolarized 13 C-labelled agent, and resulted in bSSFP-imaging being preferable for intravenous injections, and GRE-imaging being preferable for the intra-arterial injection technique.
Hyperpolarized 13 C MRA is currently unable to compete with contrast enhanced MRA. Considering the complexity of the method (primarily the need for polarizer hardware and the short life time of the signal) it is unlikely that it will become an attractive method. However, hyperpolarization is still an immature methodology, and there are areas where current MRA falls short. With further research into hyperpolarization to increase the available signal, and possibly increase the life time, there are opportunities for significant improvement. 
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